Similarly, other reports have found a dramatic increase in the activity of MMP9 in gemcitabine-resistant pancreatic cancer cells [204], which fits well within our molecular signaling platform of Neu1-MMP9 cross-talk in regulating growth factor receptors. This evidence concerns the gene NEU1 and pancreatic neoplasm.